Debio-4126

N/A

Report date: 2025/06/26 20:00:07

Base Information

Drug NameDebio-4126
Drug Alias NameSustained-release formulation of octreotideDebio 4126 controlled releaseDebio-4126Debio 4126
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSomatostatin receptor agonistsGrowth hormone releasing factor antagonists
TargetsSomatostatin receptorGrowth hormone releasing factor
Therapy Area/IndicationsGastroenteropancreatic neuroendocrine tumorAcromegaly
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaCanada +[22] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesDebiopharm International Sa
China Registration ClassN/A

Develop Information

Active CompaniesDebiopharm International Sa
Inactive CompaniesN/A
Active IndicationsAcromegaly
Inactive IndicationsGastroenteropancreatic neuroendocrine tumor

Other Information

ATC CodeH01CB02
Related LinksN/A